GIAPREZA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Feb 2025)
What this means for you
Registered since 26 Feb 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87720479
- Registration number
- 5687263
- Mark type
- Stylized text
- Filed
- 14 Dec 2017
- Published for opposition
- 15 May 2018
- Registered
- 26 Feb 2019
- Attorney of record
- Nicole Kinsley, Esq.
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals for the treatment of hypotension; antihypotensive agents
Owner
- LA JOLLA PHARMACEUTICAL COMPANY, WALTHAM, MA, US
- La Jolla Pharmaceutical Company, San Diego, CA, US
- La Jolla Pharmaceutical Company, San Diego, CA, US
- La Jolla Pharmaceutical Company, San Diego, CA, US
Prosecution history
- 08 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Feb 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Sept 2024 — TEAS SECTION 8 & 15 RECEIVED
- 22 Jul 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 26 Feb 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Feb 2019 — REGISTERED-PRINCIPAL REGISTER
- 25 Jan 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Jan 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Jan 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jan 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Jan 2019 — USE AMENDMENT FILED
- 22 Jan 2019 — SOU EXTENSION 1 GRANTED
- 10 Jan 2019 — SOU EXTENSION 1 FILED
- 22 Jan 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL